Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
In an interview to CNBC-TV18's Anuj Singhal, SP Tulsian shared his views and outlook on the fundamentals of the market and specific stocks.
Mitessh Thakkar of miteshthacker.com is of the view that one may buy PTC India, CRISIL, Gujarat Fluorochemicals and Britannia Industries and sell IndusInd Bank.
Prakash Gaba of prakashgaba.com is of the view that Blue Star can climb to Rs 715 while CRISIL may test Rs 1990.
Prakash Gaba of prakashgaba.com is of the view that CRISIL can climb to Rs 2000 and likes Fortis Healthcare.
Sumeet Jain of Destimoney Securities is of the view that one may buy Hexaware Technologies with a target of Rs 211.50.
According to Daljeet Singh Kohli of India Nivesh Securites, one can buy Credit Analysis and Research and feels that the stock may test Rs 1400.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bata India, CRISIL and NTPC.
As an investment strategy, Credit Suisse advises to bet on those segment player which have large valuation gap but give higher returns. "Large valuation gap between segment leader and small player sometimes provide an opportunity for higher stock returns to be generated by the smaller company," it adds.
In an interview to CNBC-TV18‘s Latha Venkatesh and Sonia Shenoy, SP Tulsian of sptulsian.com spoke on the market fundamentals and gave his views on specific stocks and sectors.
Taher Badshah of Motilal Oswal is of the view that CRISIL hold preference in the portfolio.
Here are top 10 stocks to focus on July 20 - Crompton Greaves, Just Dial, ACC, Federal Bank, Karnataka Bank, Oberoi Realty, Dishman Pharma, Punj Lloyd, CRISIL, Godrej Properties, Orient Green Power, TTML.
Kunal Bothra of LKP Securities is of the view that in the short term CRISIL may test Rs 2030-2030.
Rahul Arora – CEO at Nirmal Bang Instl Equities is of the view that ICICI Bank is the top pick from the banking space and is bullish on Federal Bank. "One may prefer State Bank of India," he adds.
SP Tulsian is bullish on CARE Ratings and JK Cement. He expects both these stocks to fetch high returns in future.
Buy CRISIL, says Rajesh Agarwal of Eastern Financiers
CNBC-TV18 brings you a brand new week of Bull's Eye. It's the popular game show where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.